Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revolution Medicines, Inc. (RVMD)  
$40.34 0.19 (0.47%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 163,810,000
Market Cap: 6.61(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.35 - $40.68
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. Co.'s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which Co. refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target main nodes in the RAS pathway or associated pathways, which Co. refers to as RAS Companion Inhibitors. Co.'s RAS Companion Inhibitors (example, SHP2, mTORC1 and SOS1 inhibitors) are designed primarily for combination treatment strategies involving one or more therapeutic agents, which may include its RAS(ON) Inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 950,000
Total Buy Value $0 $0 $0 $20,145,604
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 4
Total Shares Sold 77,164 149,915 341,875 392,133
Total Sell Value $2,731,464 $4,777,740 $10,977,192 $11,999,177
Total People Sold 6 6 7 8
Total Sell Transactions 14 24 47 65
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 334
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Patel Sushil   •       •      –    2024-04-10 4 AS $37.00 $79,735 D/D (2,155) 15,700 11%     
   Patel Sushil   •       •      –    2024-04-10 4 OE $16.80 $36,204 D/D 2,155 17,855     -
   Goldsmith Mark A See Remarks   •       •      –    2024-04-10 4 AS $35.33 $353,346 I/I (10,000) 30,424 11%     
   Goldsmith Mark A See Remarks   •       •      –    2024-04-10 4 AS $35.48 $266,122 D/D (7,500) 452,879 11%     
   Cislini Jeff General Counsel   •       •      –    2024-03-27 4 AS $30.38 $46,481 D/D (1,500) 54,374 27%     
   Wei Lin Chief Medical Officer   •       –      –    2024-03-21 3 IO $0.00 $0 D/D 0 74,400 24%     
   Anders Jack Chief Financial Officer   •       •      –    2024-03-18 4 AS $31.58 $39,826 D/D (1,261) 101,959 30%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-18 4 AS $31.58 $92,033 D/D (2,914) 139,553 30%     
   Goldsmith Mark A See Remarks   •       •      –    2024-03-18 4 AS $31.58 $182,804 D/D (5,788) 460,379 30%     
   Cislini Jeff General Counsel   •       •      –    2024-03-18 4 AS $31.58 $39,542 D/D (1,252) 55,874 30%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-03-18 4 AS $31.58 $67,051 D/D (2,123) 270,909 30%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-12 4 AS $34.07 $270,345 D/D (7,936) 142,467 20%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-12 4 OE $4.09 $32,458 D/D 7,936 150,403     -
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-11 4 AS $34.02 $535,306 D/D (15,735) 142,467 23%     
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-11 4 OE $4.09 $64,356 D/D 15,735 158,202     -
   Wang Xiaolin See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 24,200 84,526     -
   Anders Jack Chief Financial Officer   •       •      –    2024-03-01 4 A $0.00 $0 D/D 26,400 103,220     -
   Cislini Jeff General Counsel   •       •      –    2024-03-01 4 A $0.00 $0 D/D 21,000 57,126     -
   Horn Margaret A Chief Operating Officer   •       •      –    2024-03-01 4 A $0.00 $0 D/D 41,000 142,467     -
   Kelsey Stephen Michael See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 51,400 273,032     -
   Goldsmith Mark A See Remarks   •       •      –    2024-03-01 4 A $0.00 $0 D/D 90,000 466,167     -
   Cislini Jeff General Counsel   •       •      –    2024-01-22 4 AS $27.00 $40,500 D/D (1,500) 36,126 39%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-01-08 4 AS $29.01 $96,809 D/D (3,337) 221,632 34%     
   Kelsey Stephen Michael See Remarks   •       •      –    2024-01-02 4 AS $29.10 $387,884 D/D (13,330) 224,969 32%     
   Kelsey Stephen Michael See Remarks   •       •      –    2023-12-27 4 AS $29.01 $966,996 D/D (33,334) 238,299 31%     
  334 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us